In the current month, PHAR has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHAR average Analyst price target in the last month is 2.070.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
4
4
4
4
4
4
4
4
Buy
2
2
2
2
2
2
2
2
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
6
6
6
6
6
6
6
6
FAQs
What is the analyst rating for Pharming Group NV?
Based on the ratings of Pharming Group NV's stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.